Introduction
============

Pulmonary rehabilitation is defined as "a comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies that include, but are not limited to, exercise training, education, and behavior change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors."[@b1-copd-13-257] Pulmonary rehabilitation has well-established benefits in improving exercise capacity, health-related quality life, and psychological well-being in chronic lung conditions such as COPD.[@b1-copd-13-257],[@b2-copd-13-257] The strength of the evidence for these benefits in COPD has led to calls for an end to randomized controlled trials comparing pulmonary rehabilitation with usual care.[@b3-copd-13-257] However, the benefits of pulmonary rehabilitation have been shown to be short term[@b2-copd-13-257] with the condition of most patients returning to baseline at 12 months.[@b4-copd-13-257] Consequently, there is interest in exercise programs that may maintain the initial benefits of pulmonary rehabilitation.[@b5-copd-13-257],[@b6-copd-13-257]

Supervised maintenance exercise programs after pulmonary rehabilitation in COPD appear to be more effective in preserving the improvements in exercise capacity up to 6 months but show no effects with respect to health-related quality of life postrehabilitation.[@b5-copd-13-257],[@b7-copd-13-257] Exacerbations and hospital admissions are the key events in the management of COPD, but the effects of exercise, particularly supervised maintenance programs following pulmonary rehabilitation, on these outcomes have received little attention. A recent systematic review has highlighted the role of pulmonary rehabilitation in reducing hospitalizations due to COPD exacerbations.[@b8-copd-13-257] This supported a previous systematic review that showed a reduction in the risk of hospital readmission when completing pulmonary rehabilitation following exacerbation,[@b9-copd-13-257] albeit the quality of this evidence has recently been downgraded due to inconsistencies in the estimates of effect.[@b10-copd-13-257] There is increasing interest in assessing these outcomes in response to exercise interventions following pulmonary rehabilitation to identify if the duration of benefits from a pulmonary rehabilitation program alone can be prolonged or rather enhanced during the postrehabilitation period.[@b8-copd-13-257] A previous systematic review of supervised maintenance exercise programs following pulmonary rehabilitation in COPD had included studies that reported health care use; however, data were not statistically combined to quantify effect size.[@b5-copd-13-257] Despite the availability of new evidence in the area since this review, there remains no systematic review that has synthesized the evidence of the effects of supervised maintenance exercise training programs compared to usual care following pulmonary rehabilitation on outcomes related to health care use. Therefore, the aim of this systematic review was to collate and synthesize all of the available evidence from randomized controlled trials in order to estimate the size of the effect of supervised maintenance exercise programs following pulmonary rehabilitation on health care use.

Methods
=======

The protocol for this study (CRD42016035509) was registered in advance on PROSPERO (International Prospective Register of Systematic Reviews; [www.crd.york.ac.uk/PROSPERO/](http://www.crd.york.ac.uk/PROSPERO/)).

Selection criteria
------------------

### Participants

Adults with a confirmed diagnosis of COPD (in line with national or international criteria, eg, British Thoracic Society, American Thoracic Society/European Respiratory Society, and Global Initiative for Chronic Obstructive Lung Disease) who had completed a pulmonary rehabilitation program.[@b11-copd-13-257]--[@b13-copd-13-257]

### Intervention

Studies were included if patients were randomized to a supervised maintenance exercise training program following pulmonary rehabilitation.

### Comparison

The comparator was any concurrent control group who had completed pulmonary rehabilitation and returned to "usual care."

### Outcomes

Primary outcomes were hospital admissions (respiratory cause), exacerbations requiring treatment with antibiotics and/or systemic corticosteroids, and all-cause mortality.

Secondary outcome measures were hospital admissions (all-cause), outpatient visits, length of hospital stay (respiratory or all-cause), and general practitioner (GP) visits.

### Study design

Studies included in this review had to have adhered to the following study designs: parallel-group randomized controlled trials (allocation at individual or cluster level or using quasi-random method) or crossover randomized controlled trials (data up to point of crossover only).

Search strategy
---------------

Searches were conducted to identify any relevant completed or ongoing systematic reviews using the following sources: Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, and PROSPERO. Published trials were identified through searches on the following bibliographic databases: MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials, Web of Science, and PEDro. Searches of ongoing trial registers, such as [ClinicalTrials.gov](http://ClinicalTrials.gov) and Current Controlled Trials, were also undertaken. Gray literature was also searched via EThOS (British Library) and Conference Proceedings Index (Web of Science Core Collection). Searches were conducted from database inception to August 2017. No limits were set on language or publication status. Search terms were structured around the population (eg, "Lung Diseases, Obstructive", "COPD"), intervention (eg, "Exercise Therapy", "exercis\* N3 supervi\* OR training OR maintenance OR program\*"), and study type (eg, "randomised", "randomized", "controlled"). An example of a full search strategy for CINAHL is presented in [Table S1](#SD3-copd-13-257){ref-type="supplementary-material"}. Database searching was supplemented by contact with study authors and research groups, forward and backward citation tracking from included studies or previous relevant reviews, with further Internet searching via Google Scholar until August 2017.

Search results were collated using EndNote (Clarivate Analytics, Philadelphia, PA, USA). Duplicate citations were removed prior to independent screening of title and abstracts according to inclusion criteria by two reviewers. Full-text articles were obtained for all studies that were unable to be excluded based on title and abstract, before further independent screening to decide on final eligibility. Discrepancies in study eligibility were resolved through discussion between reviewers.

Data extraction and quality appraisal
-------------------------------------

Data extraction took place using a modified Cochrane Data Extraction Template including elements adapted from a taxonomy form previously used in randomized controlled trials.[@b14-copd-13-257] Data were extracted by one reviewer and checked for accuracy by a second reviewer. List of characteristics extracted from studies is available in the Supplementary materials.

Two reviewers independently assessed the risk of bias for included studies using the Cochrane Risk of Bias Tool with the following domains: random sequence generation, allocation concealment, blinding of outcome assessment, incomplete outcome data, selective outcome reporting, and other bias.[@b15-copd-13-257] Each domain was classified as low, unclear, or high with the risk of bias for each study classified using the following criteria: 1) low risk of bias (all criteria were deemed low), 2) medium risk of bias (one criterion graded as high or two criteria graded as unclear), and 3) high risk of bias (more than one criterion was deemed high or more than two criteria graded unclear). Disagreements between reviewers were resolved through further discussion.

Data analysis
-------------

All analyses were performed using Review Manager Version 5.3. The primary measures of effect were treated as dichotomous data (defined as the total number of participants in each group who had been hospitalized for respiratory cause, treated for an exacerbation, or died \[all-cause\]) and interpreted as risk ratios. Rate ratio of hospital admissions (respiratory-cause) and exacerbations was also calculated using the incidence rate in the intervention groups divided by the incidence rate in the control groups. Secondary outcomes of hospital admissions (all-cause), GP visits (all-cause), and outpatient visits were treated as dichotomous outcomes only and were interpreted as risk ratios. Length of hospital admissions (respiratory and all-cause) were analyzed as a continuous outcome and expressed as the between-groups difference in means. All primary and secondary outcomes were analyzed using raw data provided by authors rather than mean values presented in publications. If studies reported the same outcome measures, data were combined statistically using a random-effects meta-analysis. We contacted study authors to obtain missing numerical outcome data, and in cases where studies only reported certain outcomes of health care use, we verified that no additional data were available. The generic inverse-variance random-effects model for rates of hospitalization (respiratory) and exacerbation included the (natural) logarithms of the rate ratios and the standard error of the rate ratio.[@b15-copd-13-257] Statistical heterogeneity was assessed by the *I*^2^ value. Data were not pooled if heterogeneity was found to be moderate (*I*^2^\>30%). If heterogeneity was identified, potential sources were explored. Prespecified subgroup analyses included the setting, frequency, and delivery (training level of supervisor, combined with education) of supervised maintenance exercise programs. To test the robustness of findings in primary outcome measures, planned prespecified sensitivity analyses involved the removal of studies categorized as medium or high risk of bias within the Cochrane Risk of Bias Tool.

Results
=======

After the removal of duplicates, searches identified 3,730 records to be screened, of which 3,688 records were excluded based on title and abstract ([Figure 1](#f1-copd-13-257){ref-type="fig"}). Full texts were obtained for the remaining 42 records. Information on excluded texts and reasons for these can be found in [Table S2](#SD4-copd-13-257){ref-type="supplementary-material"}. Ten records (eight studies) met the inclusion criteria ([Table 1](#t1-copd-13-257){ref-type="table"}), of which six studies had data available for meta-analysis. Two studies were excluded from the meta-analysis due to data not being available in the appropriate format[@b16-copd-13-257] and outcome definitions (eg, exacerbation) not meeting review eligibility criteria.[@b17-copd-13-257]

Characteristics of included studies
-----------------------------------

The eight included studies were published between 2002 and 2017 ([Table 1](#t1-copd-13-257){ref-type="table"}). The eight studies, in total, randomized 790 COPD patients (64% males), with study sample sizes ranging between 40 and 164. All stages of COPD severity (airflow limitation) were represented across included studies. All studies, except Moullec et al,[@b23-copd-13-257],[@b24-copd-13-257] randomized patients to either a control group (usual care) or a supervised maintenance exercise program following pulmonary rehabilitation. Moullec et al[@b23-copd-13-257],[@b24-copd-13-257] used a quasi-random method, whereby patients were consecutively assigned following pulmonary rehabilitation discharge. All supervised maintenance exercise interventions lasted between 9 and 12 months except for Guell et al[@b25-copd-13-257] who provided a program for 36 months. Ringbaek et al[@b19-copd-13-257] and Ries et al[@b16-copd-13-257] had 6- and 12-month observation periods, respectively, following the completion of supervised maintenance exercise, data for which were not relevant for analysis in this review. Intervention procedures varied considerably between studies with one study providing an intense program of 3.5 h of supervised maintenance exercise a week,[@b23-copd-13-257],[@b24-copd-13-257] whereas another study provided one supervised maintenance session every 3 months.[@b20-copd-13-257],[@b21-copd-13-257] More details on interventions for all of the studies are given in [Table 1](#t1-copd-13-257){ref-type="table"}.

Primary and secondary outcomes of this review were determined by either self-reporting of events by patients[@b16-copd-13-257],[@b17-copd-13-257] or self-report validated through examination of health records.[@b18-copd-13-257]--[@b25-copd-13-257] Health care use was reported as a secondary outcome in the majority of studies[@b16-copd-13-257]--[@b24-copd-13-257] with the publication of one study not reporting relevant outcomes.[@b25-copd-13-257] Contact with authors of this study provided unpublished data relevant to this review. None of the studies had outcome data for all planned meta-analyses.

The risk of bias assessment was hindered by poor study reporting. Some studies presented with several unclear risks of bias domains, leading to overall high risk of bias. Due to high attrition rates, the risk of bias in four of the included studies in the meta-analyses was classified as high ([Table 2](#t2-copd-13-257){ref-type="table"}). The only study with a low risk of bias was unable to be included in meta-analyses due to the lack of availability of data.[@b16-copd-13-257]

Primary outcomes
----------------

### Hospital admissions (respiratory cause)

Meta-analysis of five trials[@b18-copd-13-257],[@b20-copd-13-257],[@b22-copd-13-257]--[@b25-copd-13-257] demonstrated a statistically significant reduction in the risk of experiencing at least one respiratory-cause hospital admission with continued supervised maintenance exercise following pulmonary rehabilitation (risk ratio 0.62, 95% confidence interval (CI) 0.47--0.81, *P*\<0.001) ([Figure 2A](#f2-copd-13-257){ref-type="fig"}). There were no indications of heterogeneity in the findings (*I*^2^=0%).

Three trials provided data on incidence rates,[@b18-copd-13-257],[@b20-copd-13-257],[@b25-copd-13-257] whereby the overall estimate of the average effect suggested a reduction in the rate of respiratory-cause hospital admissions with supervised maintenance exercise (rate ratio 0.72, 95% CI 0.50--1.05, *P*=0.09, *I*^2^=0%) ([Figure 2B](#f2-copd-13-257){ref-type="fig"}).

### Exacerbations requiring treatment with antibiotics and/or systemic corticosteroids

Meta-analysis of two trials[@b18-copd-13-257],[@b22-copd-13-257] suggested a reduction in the risk of experiencing at least one exacerbation with supervised maintenance exercise (risk ratio 0.79, 95% CI 0.52--1.19, *P*=0.25, *I*^2^=0%) ([Figure 3A](#f3-copd-13-257){ref-type="fig"}). Synthesis of the incidence rates of exacerbations in these studies suggested a minimal effect of supervised maintenance exercise (rate ratio 0.95, 95% CI 0.67--1.37, *P*=0.80, *I*^2^=0%) ([Figure 3B](#f3-copd-13-257){ref-type="fig"}).

### Mortality

Meta-analysis of two trials[@b18-copd-13-257],[@b20-copd-13-257] suggested a reduction in the risk of all-cause mortality with supervised maintenance exercise, but this was not statistically significant (risk ratio 0.57, 95% CI 0.17--1.92, *P*=0.37, *I*^2^=0%) ([Figure 4](#f4-copd-13-257){ref-type="fig"}). The trial by Roman et al[@b22-copd-13-257] was omitted from this analysis due to no events occurring in either group during the trial.[@b15-copd-13-257]

Secondary outcomes
------------------

### Hospital admissions (all-cause)

Meta-analysis of three trials[@b19-copd-13-257],[@b20-copd-13-257],[@b23-copd-13-257] suggested a greater risk of experiencing at least one all-cause hospital admission with supervised maintenance exercise (risk ratio 1.14, 95% CI 0.80--1.62, *P*=0.48, *I*^2^=0%) ([Figure S1](#SD1-copd-13-257){ref-type="supplementary-material"}).

### Length of stay (respiratory cause and all-cause)

One trial provided data for length of hospital stay due to respiratory cause[@b18-copd-13-257] (mean difference −1.60, 95% CI −4.73 to 1.53, *P*=0.32), and one trial provided data for length of hospital stay due to all-cause[@b19-copd-13-257] (mean difference −0.20, 95% CI −2.31 to 1.91, *P*=0.85) with both favoring a shorter length of stay with supervised maintenance exercise.

### Outpatient visits

Only one trial provided data for outpatient visits.[@b20-copd-13-257] The overall estimate of effect suggested a nonsignificant reduction in the risk of experiencing at least one outpatient visit with supervised maintenance exercise (risk ratio 0.78, 95% CI 0.53--1.14, *P*=0.20).

### GP visits

Meta-analysis of three trials[@b18-copd-13-257],[@b20-copd-13-257],[@b22-copd-13-257] suggested a minimal reduction in the number of patients making at least one GP visit with supervised maintenance exercise (risk ratio 0.92, 95% CI 0.75--1.11, *P*=0.38, *I*^2^=0%) ([Figure S2](#SD2-copd-13-257){ref-type="supplementary-material"}).

Sensitivity analyses
--------------------

As all studies included in the meta-analyses were assessed to have a medium or high risk of bias, we were unable to perform our prespecified sensitivity analyses. However, we deemed that a sensitivity analysis was required on our outcome of the risk of respiratory-cause hospital admissions due to the presence of one study[@b25-copd-13-257] that had a substantially longer intervention (and follow-up period) (36 months).

Assessing the number of patients suffering one or more exacerbation between groups (ie, risk ratio) will show the direction of the intervention effect, but it is heavily influenced by the duration of the trial.[@b26-copd-13-257] Pooled analyses excluding Guell et al[@b25-copd-13-257] led to the loss of statistical significance and reduction in the overall effect of supervised maintenance exercise on the overall risk of experiencing at least one respiratory-cause admission (risk ratio 0.81, 95% CI 0.43--1.52, *P*=0.51) ([Figure 5](#f5-copd-13-257){ref-type="fig"}). Admission data were also retrieved from the study authors for the 1 year follow-up of this study, to allow further scrutiny of the effect of the duration of follow-up. Pooled analyses including the 12-month follow-up of Guell et al[@b25-copd-13-257] also led to loss of statistical significance and reduction in the overall effect of supervised maintenance exercise on the overall risk of experiencing at least one respiratory-cause hospital admission (risk ratio 0.77, 95% CI 0.47--1.25, *P*=0.29) ([Figure 6](#f6-copd-13-257){ref-type="fig"}). Due to limited number of completed trials, it was not possible to perform meaningful synthesis of prespecified subgroups on our primary outcomes.

Discussion
==========

To our knowledge, this is the first systematic review to identify eight completed randomized trials that compared the efficacy of supervised maintenance exercise following pulmonary rehabilitation with usual care on health care use in COPD, six of which had relevant data to be synthesized using meta-analysis.

Summary of main findings
------------------------

Data synthesis of five trials[@b18-copd-13-257],[@b20-copd-13-257],[@b22-copd-13-257]--[@b25-copd-13-257] suggests that, on average, supervised maintenance exercise following pulmonary rehabilitation significantly reduces the risk of experiencing at least one respiratory-cause hospital admission by 38%. The current available evidence is heavily weighted by one trial,[@b25-copd-13-257] whereby the magnitude of the point estimate is sensitive to the inclusion of this trial (due to length of follow-up). Synthesized data from three trials[@b18-copd-13-257],[@b20-copd-13-257],[@b25-copd-13-257] suggest that, on average, supervised maintenance exercise may also have an effect on multiple admissions by reducing the rate of respiratory-cause admissions by 28%. While pooling of studies for other primary measures in this review (relative risk reduction in exacerbations requiring treatment with antibiotics and/or systemic corticosteroids and all-cause mortality of 21% and 43%, respectively) did not translate to statistically significant changes, the point estimates of effect do surpass proposed thresholds of clinical significance.[@b26-copd-13-257],[@b27-copd-13-257] There is currently no evidence that supervised maintenance exercise following pulmonary rehabilitation has an effect on the risk of all-cause hospital admission or GP visits. Furthermore, there are insufficient data to synthesize the effect of supervised maintenance exercise on outpatient visits or duration of hospital stay following respiratory-cause and all-cause admission.

Strengths and limitations of the review
---------------------------------------

A strength of this review is that it is the first to conduct comprehensive searches and synthesis of published and unpublished data on health care use during supervised maintenance exercise programs compared to usual care following pulmonary rehabilitation. This review followed a preset, publicly available protocol detailing specific methodology. When the protocol for this review was written however, we did not anticipate the inclusion of trials with substantial differences in study follow-up. The recent study of Guell et al[@b25-copd-13-257] has received plaudits for conducting such a long follow-up period of postpulmonary rehabilitation maintenance.[@b28-copd-13-257] We feel that this deviation from our protocol in performing sensitivity analysis was strongly justified on the basis that studies with a longer observation period are likely to impact the robustness of our findings.

Extensive efforts were made to contact all trial authors to obtain additional data when outcomes did not appear in the available reports. The retrieval of additional data (beyond the published literature) reflects a key strength of our review. We, however, recognize that two studies[@b16-copd-13-257],[@b17-copd-13-257] that met review eligibility criteria were not included in our meta-analyses; hence, this must be noted as a limitation. We identified inconsistencies in how our review outcomes were reported. The majority of the studies were limited by expressing hospitalizations/exacerbations as mean number of events per study group only and simply interpreted as a difference in means. However, a small minority of patients who experience multiple events can heavily influence this measure of effect, and the interpretation of such estimates is not as informative as when discrete (count) data are analyzed as ratios. From a statistical point of view, a strength of our review is that our measures of effect make full use of the data that have been collected in the included studies. Clinically, we allow health care practitioners and other relevant stakeholders to be able to interpret the effect of supervised maintenance exercise on the risk of whether a patient experiences an exacerbation and the efficacy of the intervention in reducing multiple events in the same patient.

The proposed minimal clinically important difference in COPD exacerbation frequency is 20%.[@b26-copd-13-257],[@b27-copd-13-257] As the entire range of the confidence interval for the effect of supervised maintenance exercise on hospitalization rates (ie, severe exacerbation) or risk of an exacerbation treated with antibiotics and/or systemic corticosteroids does not exceed the threshold of clinical usefulness, we cannot exclude the possibility that the reduction is of a magnitude not considered clinically worthwhile. Hence, the available evidence can be considered consistent with either an increase or a decrease in hospitalization rates (ie, severe exacerbation) or risk of an exacerbation as a result of the intervention.

The proportion of missing outcome data compared to observed outcome data in some of the trials[@b20-copd-13-257]--[@b25-copd-13-257] is enough to induce a clinically relevant bias in the observed intervention effects. There is no consensus on how to handle participants in a meta-analysis for whom data are not available.[@b15-copd-13-257] We opted for an available case analysis as opposed to intention to treat analysis using imputation. Although our findings do provide an analysis of efficacy, the lack of intention to treat approach precludes an effectiveness analysis of the supervised maintenance exercise.[@b29-copd-13-257]

Effects estimated from published studies only may be inflated due to bias toward the nonpublication of studies with nonsignificant effects. The fact that all of the included published studies did not report significant effects of supervised maintenance exercise on health care use mitigates concerns about publication bias. All of the trials included in the meta-analyses were classified as having an overall medium or high risk of bias. Therefore, the quality of the overall evidence presented in this review is low. There were many individual domains where the risk of bias was unclear, primarily due to incomplete reporting. It is important to consider that this may not be poor reporting per se, and rather limitations in study design.[@b30-copd-13-257] Also, as commonly found in COPD trials, especially those \>6 months in duration, many studies were classified as having high attrition bias.[@b31-copd-13-257]

Comparison with other reviews
-----------------------------

No previous systematic review has synthesized data from randomized controlled trials assessing the effects of supervised maintenance exercise following pulmonary rehabilitation on health care use. There were three previous systematic reviews in COPD that had synthesized the available evidence on supervised maintenance programs following pulmonary rehabilitation, but meta-analyses were limited to exercise capacity and quality of life outcomes.[@b5-copd-13-257],[@b7-copd-13-257],[@b32-copd-13-257] Similarities, with regard to the benefits of exercise in our review, can be seen with Moore et al[@b8-copd-13-257] where data from randomized controlled trials on health care use following pulmonary rehabilitation alone were synthesized. However, this review did not focus on interventions aiming to maintain exercise regimens following pulmonary rehabilitation but instead evaluated the short- and long-term benefits of initial pulmonary rehabilitation programs on exacerbations compared to no treatment. It was concluded that the delivery of pulmonary rehabilitation to stable COPD patients or patients following acute exacerbations results in reduced rates of hospitalizations compared to usual care. Our findings suggest that continuing maintenance exercise in a supervised manner following pulmonary rehabilitation may further enhance the benefit on certain health care use outcomes.

Implications for clinical practice
----------------------------------

Based on the evidence presented in this review, it would currently be unwise to make specific recommendations on clinical care within this area. Due to the low precision (wide confidence intervals) in our effect estimates, only one of our meta-analyses translated to a statistically significant difference in health care use as a result of supervised maintenance exercise. However, early indications are promising, whereby the current point estimates of effect in some of the outcomes (eg, exacerbation rate) would be large enough to be classified as clinically significant. These clinically significant findings could have large implications for future postrehabilitation care. While there are proposals that "one size does not fit all" with pulmonary rehabilitation maintenance,[@b28-copd-13-257] supervised maintenance exercise will likely play an important part in future practice recommendations. Arguably, the funding and reimbursement of supervised maintenance programs may largely depend on evaluations of cost-effectiveness. In theory, offering continued supervised maintenance exercise programs following pulmonary rehabilitation may not be cost-effective in the short term due to the initial outlay of setting up a program;[@b21-copd-13-257],[@b33-copd-13-257] however, the potential reductions in health care use in the medium to long term seen within this review may be large enough to produce a favorable cost--benefit ratio to health care budgets. This review highlights the importance of this active area of research and upon completion of further studies, its influence on future clinical practice.

Implications for future research
--------------------------------

The findings of our meta-analyses must be interpreted in relation to quality and quantity of available evidence. The low precision of the individual study estimates (as a result of small sample sizes and hence low number of events) widens the confidence intervals for the point estimates of effect, highlighting the important impact that further research could have.

Further randomized trials addressing the current uncertainty about the effects of supervised maintenance exercise versus usual care on outcomes such as mortality and risk of exacerbation would need to be large (in sample size and/or a duration of follow-up ≥12 months). None of the included studies reported an a priori sample size calculation to determine the effect of supervised maintenance exercise on outcomes related to health care use.[@b18-copd-13-257],[@b20-copd-13-257],[@b22-copd-13-257],[@b25-copd-13-257] Future studies should include an appropriately powered sample size calculation based on proposed minimal clinically important differences. These studies should also adopt proper statistical analysis of outcomes (particularly exacerbations). Typical distribution of COPD exacerbations data and recommended statistical approaches have been discussed elsewhere.[@b34-copd-13-257],[@b35-copd-13-257] To facilitate critical appraisal and interpretation, future randomized trials would also benefit from adhering to Consolidated Standards of Reporting Trials (CONSORT) guidelines.

Our findings have general applicability to all stable COPD patients referred to pulmonary rehabilitation. As none of the included trials stratified randomization by COPD severity, it is unclear whether our findings are equally applicable to all stages of COPD severity or exacerbation status. Further research is required to ascertain the effects of supervised maintenance exercise programs following early rehabilitation programs where patients are inherently considered to have a greater baseline risk of health care use. Similarly, our review was limited to patients with a diagnosis of COPD; efficacy of exercise maintenance options for other chronic respiratory conditions requires attention.

During our searches, we identified two protocols of randomized trials (based in the USA and Canada) that meet our eligibility criteria ([Table S3](#SD5-copd-13-257){ref-type="supplementary-material"}).[@b36-copd-13-257],[@b37-copd-13-257] Compared to usual care following pulmonary rehabilitation, one study[@b36-copd-13-257] is randomizing patients to Tai Chi classes, or a walking group for a 6-month period, while another study[@b37-copd-13-257] is randomizing patients to a 12-month community exercise program. An update on the synthesis of the available evidence would be encouraged upon completion of the trials. For the design and delivery of new trials, research teams should note recent recommendations from the Australian and New Zealand Pulmonary Rehabilitation Guidelines[@b6-copd-13-257] that maintenance programs of monthly or three monthly supervised exercises (or less frequently) are insufficient to maintain exercise capacity or quality of life. It is reasonable to suggest that this frequency of supervised maintenance exercise compared with usual care is also unlikely to benefit outcomes related to health care use. However, we recognize that there is growing interest in different approaches to maintain the benefits of pulmonary rehabilitation, for example, telerehabilitation,[@b38-copd-13-257] telecoaching,[@b39-copd-13-257] and pedometer feedback.[@b40-copd-13-257]

Conclusion
==========

This systematic review and meta-analysis suggests that supervised maintenance exercise programs compared to usual care following pulmonary rehabilitation may be beneficial in reducing health care use. However, the quality of the available evidence was variable. This outlines the requirement for methodologically sound and large studies to provide more precise estimates for the effects of postpulmonary rehabilitation maintenance.

Supplementary materials
=======================

Methods
-------

### Data extraction

The following study characteristics were extracted: methods of the study (date/title of the study, aim of study, study design, unit of allocation, duration of study, duration of intervention, primary outcome, secondary outcomes, and funding source), participants (population description, demographics, inclusion criteria, exclusion criteria, method of recruitment of participants, total number randomized, clusters, baseline imbalances, withdrawal and exclusions, and subgroups reported), intervention and where relevant comparator (group name, number randomized to group-sample size, description, venue numbers/locations, duration and frequency of maintenance exercise training period, delivery, providers, co-interventions, compliance/adherence, and defined parameters of usual care), and outcomes (outcome name, outcome type, outcome definition, person measuring/reporting, unit of measurement, scales \[upper and lower limits\], outcome tool validation, imputation of missing data, assumed risk estimate, and level of power).

###### 

Trial-level data, effect estimates, and forest plot of comparison for the risk of all-cause hospital admission.

**Abbreviations:** CI, confidence interval; IV, inverse variance.

###### 

Trial-level data, effect estimates, and forest plot of comparison for the risk of GP visits.

**Abbreviations:** CI, confidence interval; GP, general practitioner; IV, inverse variance.

###### 

Example search strategy of a bibliographic database (CINAHL)

  Number   Search term                                                                                                                                                                                    Field
  -------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------
  1        Lung diseases, obstructive                                                                                                                                                                     MH (explode)
  2        Lung diseases, interstitial                                                                                                                                                                    MH (explode)
  3        Pulmonary fibrosis                                                                                                                                                                             MH (explode)
  4        COPD                                                                                                                                                                                           TX
  5        Chronic obstructive pulmonary disease                                                                                                                                                          TX
  6        COAD                                                                                                                                                                                           TX
  7        COBD                                                                                                                                                                                           TX
  8        Emphysem[\*](#tfn3-copd-13-257){ref-type="table-fn"}                                                                                                                                           TX
  9        Chronic bronchitis                                                                                                                                                                             TX
  10       Cystic fibrosis                                                                                                                                                                                TX
  11       Pneumoconiosis                                                                                                                                                                                 TX
  12       Sarcoidosis                                                                                                                                                                                    TX
  13       Asthma                                                                                                                                                                                         TX
  14       Bronchiectasis                                                                                                                                                                                 TX
  15       Alveolitis                                                                                                                                                                                     TX
  16       Histiocytosis                                                                                                                                                                                  TX
  17       Granulomatosis                                                                                                                                                                                 TX
  18       Bagassosis                                                                                                                                                                                     TX
  19       Asbestosis OR byssinosis OR siderosis OR silicosis OR berylliosis OR anthracosilicosis                                                                                                         TX
  20       Scleroderma                                                                                                                                                                                    TX
  21       1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20                                                                                    
  22       Exercise therapy                                                                                                                                                                               MH (explode)
  23       Activities of daily living                                                                                                                                                                     MH (explode)
  24       Rehabilitation research                                                                                                                                                                        MH
  25       Physical and rehabilitation medicine                                                                                                                                                           MH (explode)
  26       Physical fitness                                                                                                                                                                               MH
  27       Exercise movement techniques                                                                                                                                                                   MH (explode)
  28       Telerehabilitation                                                                                                                                                                             MH
  29       Rehabilitation N2 pulmonary OR respiratory OR physical OR early                                                                                                                                TI, AB
  30       Exercis[\*](#tfn3-copd-13-257){ref-type="table-fn"} N3 supervi[\*](#tfn3-copd-13-257){ref-type="table-fn"} OR training OR maintenance OR program[\*](#tfn3-copd-13-257){ref-type="table-fn"}   TI, AB
  31       Physical activit[\*](#tfn3-copd-13-257){ref-type="table-fn"}                                                                                                                                   TI, AB
  32       Maintenance N2 intervention OR group OR exercise OR program[\*](#tfn3-copd-13-257){ref-type="table-fn"} OR training                                                                            TI, AB
  33       22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32                                                                                                                                 
  34       Randomised                                                                                                                                                                                     TI, AB
  35       Randomized                                                                                                                                                                                     TI, AB
  36       Randomly                                                                                                                                                                                       TI, AB
  37       Trial                                                                                                                                                                                          TI, AB
  38       Controlled                                                                                                                                                                                     TI, AB
  39       34 OR 35 OR 36 OR 37 OR 38                                                                                                                                                                     
  40       21 AND 33 AND 39                                                                                                                                                                               

**Notes:** Searches encompassed other chronic lung conditions as part of a wider review.

Truncation operator.

###### 

Characteristics of excluded studies

  Study                                                                                         Reason(s) for exclusion
  --------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  Andrews et al (2015)[@b41-copd-13-257]                                                        Not a randomized trial
  Bernocchi et al (2016)[@b42-copd-13-257]                                                      Intervention not relevant (unsupervised)
  Berry et al (2003)[@b43-copd-13-257]                                                          Outcomes not applicable
  Bertolini et al (2016)[@b44-copd-13-257]                                                      Not randomized; outcomes not applicable; intervention not relevant (unsupervised)
  Brooks et al (2002)[@b45-copd-13-257]                                                         Outcomes not applicable
  Browne et al (2013)[@b46-copd-13-257]                                                         Conference abstract -- full text included
  Carrieri-Kohlman et al (2005)[@b47-copd-13-257]                                               Intervention not relevant (did not include pulmonary rehabilitation)
  Cejudo et al (2014)[@b48-copd-13-257]                                                         Conference abstract -- full text included; outcomes not applicable
  Cejudo et al (2014)[@b49-copd-13-257]                                                         Conference abstract -- full text included; outcomes not applicable
  Cruz et al (2016)[@b50-copd-13-257]                                                           Intervention not relevant (behavioral feedback intervention-unsupervised)
  Desveaux et al (2016)[@b51-copd-13-257]                                                       Ongoing trial -- data not available
  du Moulin et al (2009)[@b52-copd-13-257]                                                      Intervention not relevant (unsupervised); outcomes not applicable
  Eisner and van Straten (2003)[@b53-copd-13-257],[a](#tfn5-copd-13-257){ref-type="table-fn"}   Conference title only
  Elliott et al (2004)[@b54-copd-13-257]                                                        Outcomes not applicable
  Fu et al (2016)[@b55-copd-13-257]                                                             Intervention not relevant (no exercise intervention post-pulmonary rehabilitation)
  Gomez et al (2006)[@b56-copd-13-257]                                                          Conference abstract -- full text included
  Guell et al (2000)[@b57-copd-13-257]                                                          Intervention not relevant (control group did not receive pulmonary rehabilitation)
  Heppner et al (2006)[@b58-copd-13-257]                                                        Not a randomized trial
  Hill and McDonald (2004)[@b59-copd-13-257]                                                    Outcomes not applicable
  Kotrach et al (2016)[@b60-copd-13-257]                                                        Intervention not relevant (unsupervised)
  Linneberg et al (2012)[@b61-copd-13-257]                                                      Outcomes not applicable
  Martinez et al (2008)[@b62-copd-13-257]                                                       Conference abstract -- full text included
  Moy et al (2015)[@b63-copd-13-257]                                                            Ongoing trial -- data not available
  Perumal et al (2010)[@b64-copd-13-257]                                                        Not a randomized trial
  Pleguezuelos et al (2013)[@b65-copd-13-257]                                                   Intervention not relevant (unsupervised); outcomes not applicable
  Ries et al (2008)[@b66-copd-13-257]                                                           Intervention not relevant (unsupervised and control group received additional care); outcomes not applicable
  Ringbaek et al (2009)[@b67-copd-13-257]                                                       Conference abstract -- full text included
  Rodriguez-Trigo et al (2011)[@b68-copd-13-257]                                                Conference abstract -- full text included
  Scalvini et al (2016)[@b69-copd-13-257]                                                       Intervention not relevant (unsupervised)
  Spencer et al (2007)[@b70-copd-13-257]                                                        Conference abstract -- full text included
  Spencer et al (2009)[@b71-copd-13-257]                                                        Conference abstract -- full text included
  Swerts et al (1990)[@b72-copd-13-257]                                                         Outcomes not applicable
  van Wetering et al (2010)[@b73-copd-13-257]                                                   Intervention not relevant (control group did not receive pulmonary rehabilitation); outcomes not applicable
  Vasilopoulou et al (2017)[@b74-copd-13-257]                                                   Intervention not relevant (control group did not receive pulmonary rehabilitation)

**Notes:** Abstract and full text were nonretrievable.

Study excluded due to presentation as a conference title only in search results.

###### 

Ongoing studies

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study name or title                                                                                                                                                        Study period (start and end dates) (country)   Study design                                Participants                                                                            Intervention and comparison                                                                                  Relevant outcomes
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------- ------------------------------------------- --------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------
  LEAP: design and rationale of a randomized controlled trial of Tai Chi[@b63-copd-13-257]                                                                                   August 2012 to September 2017 (USA)            Randomized controlled trial (2:2:1 ratio)   90 COPD patients who have just been discharged from pulmonary rehabilitation            1\. Tai Chi (1 h, twice a week for 3 months, then once a week for 3 months. A total of 36 classes)\          Hospital admissions (respiratory) and acute exacerbations (use of corticosteroids and/or antibiotics verified by medical records)
                                                                                                                                                                                                                                                                                                                                                                2. Usual care (general recommendations for exercise)\                                                        
                                                                                                                                                                                                                                                                                                                                                                3. Walking group (same frequency and duration as Tai Chi)                                                    

  Effects of a community-based, postrehabilitation exercise program in COPD: protocol for a randomized controlled trial with embedded process evaluation[@b51-copd-13-257]   November 2012 to August 2018 (Canada)          Randomized controlled trial                 100 COPD patients who have completed pulmonary rehabilitation within the last 2 weeks   1\. Usual care (standard home exercise instructions postpulmonary rehabilitation)\                           Exacerbations (self-reported)
                                                                                                                                                                                                                                                                                                                                                                2. Community-based exercise program (1 h, minimum of two sessions per week (option to do more) for 1 year)   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviation:** LEAP, long-term exercise after pulmonary rehabilitation.

We acknowledge the cooperation of authors (Rosa Guell, Pilar Cejudo Ramos, Lissa Spencer, Miguel Roman, Magdalena Esteva, Thomas Ringbaek, Ed Wilson, and Greg Moullec) of the included studies in this review for providing data in a format appropriate for analyses. We also thank Marilyn Moy, Laura Desveaux, and Dina Brooks for providing updates on their current ongoing trials related to this review. This review was conducted during Alex R Jenkins' PhD studentship, which was part of the Doctoral Training Alliance Applied Biosciences for Health Programme.
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![Flow diagram of study selection.\
**Note:** ^a^Some studies excluded for multiple reasons.](copd-13-257Fig1){#f1-copd-13-257}

![Trial-level data, effect estimates, and forest plot of comparison for the overall risk (of experiencing at least one event) (**A**) and incidence rates (**B**) of respiratory-cause hospitalization.\
**Abbreviations:** CI, confidence interval; IV, inverse variance; SE, standard error.](copd-13-257Fig2){#f2-copd-13-257}

![Trial-level data, effect estimates, and forest plot of comparison for the overall risk (of experiencing at least one event) (**A**) and incidence rates (**B**) of exacerbation requiring treatment with medication.\
**Abbreviations:** CI, confidence interval; IV, inverse variance; SE, standard error.](copd-13-257Fig3){#f3-copd-13-257}

![Trial-level data, effect estimates, and forest plot of comparison for the risk of mortality.\
**Abbreviations:** CI, confidence interval; IV, inverse variance.](copd-13-257Fig4){#f4-copd-13-257}

![Sensitivity analyses on trial-level data, effect estimates, and forest plot of comparison for the risk of hospital admission for a respiratory cause excluding Guell et al.[@b25-copd-13-257]\
**Abbreviations:** CI, confidence interval; IV, inverse variance.](copd-13-257Fig5){#f5-copd-13-257}

![Sensitivity analyses on trial-level data, effect estimates, and forest plot of comparison for the risk of hospital admission for a respiratory cause including 0--12 months follow-up of Guell et al.[@b25-copd-13-257]\
**Abbreviations:** CI, confidence interval; IV, inverse variance.](copd-13-257Fig6){#f6-copd-13-257}

###### 

Characteristics of included studies

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study (country)                                                                                  Sample size, gender, age            FEV~1~% predicted (spirometry), smoking history                                                                 Inclusion/exclusion criteria                                                                                                                                                                                                                                                                                                                                                                                                                                           Study aim, design, unit of allocation                                                                                                                                                                                          Pulmonary rehabilitation program (setting, components, duration, frequency)                                                                                                                                                                                                                                                                                                                                 Maintenance program (setting, components, duration, frequency)                                                                                                                                                                                                                                                                                                                                                       Primary outcome (1) and other outcomes and follow-up (2)
  ------------------------------------------------------------------------------------------------ ----------------------------------- --------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------
  Ries et al (2003)[@b16-copd-13-257] (USA)                                                        164 participants\                   FEV~1~%pred, mean All: 45%\                                                                                     Inclusion: clinical diagnosis of chronic lung disease; chronic symptoms and perceived disability from disease; stable state; no other significant medical or psychiatric conditions that would interfere with program participation; commitment to abstain from smoking                                                                                                                                                                                                Assess a telephone-based maintenance intervention for retaining benefits following pulmonary rehabilitation RCT, cluster                                                                                                       Exercise and education combined with psychosocial support Twelve 2 h sessions over 8 weeks                                                                                                                                                                                                                                                                                                                  Weekly semistructured phone calls and monthly supervised reinforcement sessions (1.5 h supervised exercise, 1.0 h topic review, 0.5 h social time) for 12 months                                                                                                                                                                                                                                                     \(1\) Pulmonary function, exercise tolerance, dyspnea, depression\
                                                                                                   Int: n=83\                          No data available for smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (2) QoL, health status, health care use
                                                                                                   Con: n=81\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Males: n=89\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                   Females: n=75\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                   Age, mean ± SD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                   All: 67±8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Brooks et al (2002)[@b17-copd-13-257] (Canada)                                                   85 participants\                    FEV~1~%pred, mean ± SD\                                                                                         Inclusion: severe stable COPD (FEV~1~\<40% predicted, FEV~1~/FVC \<0.70); completion of inpatient or outpatient rehabilitation; nonsmoker for a minimum of 6 months; aged 49--85 years Exclusion: coexisting conditions that might limit exercise tolerance or cognitive functioning; noncompliance with respiratory rehabilitation; mechanical ventilatory support for any part of the day; inability to communicate in English; living too far away to participate   Compare the effects of two postrehabilitation programs on functional exercise capacity and health-related QoL in patients with COPD RCT, individual                                                                            Exercises -- breathing, treadmill or cycle exercises, interval and upper extremity training, leisure walking Patient education and psychosocial support included (relaxation and occupational therapies) Inpatient -- five times a week for 6 weeks Outpatient -- three times a week at the center and at home for 8 weeks                                                                                  Monthly 2 h group sessions supervised by a physical therapist for 12 months. First hour for discussion around home exercise program, second hour for performing components of the home exercise program under supervision. Phone calls made between visits with standardized questions regarding adherence to home exercises                                                                                         \(1\) 6MWT, CRQ\
                                                                                                   Int: n=37\                          Int: 32±2%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            (2) Medical outcomes survey: short-form 36, SGRQ, subject compliance, pulmonary function
                                                                                                   Con: n=48\                          Con: 32±2% All nonsmokers for at least 6 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                   Males: n=50\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                   Females: n=35\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                   Age, mean ± SD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                   Int: 68±1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Con: 68±1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Spencer et al (2010)[@b18-copd-13-257] (Australia)                                               48 participants\                    FEV~1~%pred, mean ± SD\                                                                                         Inclusion: COPD diagnosis; completed an 8 week pulmonary rehabilitation program; FEV~1~/FVC \<70% and FEV~1~\<80% predicted Exclusion: exacerbation in previous month; supplemental oxygen; comorbidities that would prevent performing exercises; clinic patients (pulmonary rehabilitation)                                                                                                                                                                          Determine if weekly supervised exercise following pulmonary rehabilitation would maintain functional exercise capacity and QoL RCT, individual                                                                                 Exercises -- 20 min walking, 20 min cycling, 10 min arm cycling, upper and lower limb strength training 8 weeks in a pulmonary rehabilitation gym                                                                                                                                                                                                                                                           Pulmonary rehabilitation gym for 12 months. Supervised exercise 1 day/week with unsupervised exercise 4 days/week. Exercises prescribed in line with exercise undertaken during pulmonary rehabilitation                                                                                                                                                                                                             \(1\) 6MWT, SGRQ\
                                                                                                   Int: n=24\                          Int: 57±21%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (2) Lung function tests, ISWT, ESWT, HADS, hospital admissions, length of stay and exacerbations
                                                                                                   Con: n=24\                          Con: 60±16% Current smokers\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                   Males: n=22\                        Int: n=6\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                   Females: n=26\                      Con: n=5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                   Age, mean ± SD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                   Int: 65±8\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Con: 67±7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Ringbaek et al (2010)[@b19-copd-13-257] (Denmark)                                                96 participants\                    FEV~1~%pred, mean ± SD\                                                                                         Inclusion: stable COPD (FEV~1~ \<80%, FEV~1~/FVC \<70%); motivation for pulmonary rehabilitation; completion of 7 weeks of pulmonary rehabilitation Exclusion: musculoskeletal, cardiac or cognitive problems                                                                                                                                                                                                                                                          Examine whether maintenance training improved long-term effect of pulmonary rehabilitation RCT, individual                                                                                                                     Supervised walking and cycling both at 85% of predicted VO~2\ peak~ and unsupervised exercise at home Twice a week for 7 weeks with supplementary education once a week                                                                                                                                                                                                                                     Weekly supervised exercise for the first 6 months, every second week for the next 6 months, and no supervised exercise for the last 6 months. Unsupervised exercise at home encouraged                                                                                                                                                                                                                               \(1\) ESWT, SGRQ\
                                                                                                   Int: n=55\                          Int: 36±14%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (2) Hospitalization (time to first admission, admission rates, days in hospital), exercise adherence, attendance at evaluation visits
                                                                                                   Con: n=41\                          Con: 37±16% Current smokers\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                   Males: n=31\                        Int: n=13\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                   Females: n=63 Age, mean ± SD\       Con: n=7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                   Int: 67±1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Con: 69±9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Wilson et al (2015)[@b20-copd-13-257] and Burns et al (2016)[@b21-copd-13-257] (UK)              148 participants\                   FEV~1~%pred, mean ± SD All: 41±16% \>20 pack-year smoking history No data available on current smoking status   Inclusion: \>35 years of age; COPD diagnosis (FEV~1~\<80%); \>20 pack-year smoking history; completed at least 60% of pulmonary rehabilitation sessions\                                                                                                                                                                                                                                                                                                               Evaluate long-term effect of maintenance exercise on health-related QoL Assess the cost-effectiveness of maintenance exercise following pulmonary rehabilitation on health-related QoL RCT, individual                         Exercises -- walking, cycling, sit to stand, step-ups, arm exercises with dumbbells. High intensity (85% of maximum capacity) Once a week for 8 weeks (1 h for exercise and 1 h for education). Endurance exercise everyday and strength exercise two more times a week at home                                                                                                                             Individually tailored strength and endurance exercises including walking, cycling, sit-to-stand, step-ups, and arm exercises with dumbbells One 2 h (1 h exercise and 1 h education) session every 3 months for 12 months. Same group of patients from original pulmonary rehabilitation. Home exercise program review                                                                                               \(1\) CRQ (dyspnea)\
                                                                                                   Int: n=73\                                                                                                                                          Exclusion: cardiac or pulmonary disease (other than COPD); myocardial infarction within 6 months or unstable angina; respiratory infection within last 4 weeks; uncontrolled or severe comorbidities; cognitive complications                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          (2) CRQ (other domains), ESWT, BMI, body fat, HADS, EQ5D
                                                                                                   Con: n=75\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Males: n=91\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                   Females: n=57 Age, mean ± SD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                   Int: 67±15\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                   Con: 69±9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Roman et al (2013)[@b22-copd-13-257] (Spain)                                                     71 participants\                    FEV~1~%pred, mean (95% CI)\                                                                                     Inclusion: 35--74 years old; moderate COPD diagnosis; smokers or nonsmokers\                                                                                                                                                                                                                                                                                                                                                                                           Use maintenance postpulmonary rehabilitation to improve QoL in COPD RCT, individual                                                                                                                                            Exercises -- low intensity peripheral muscle training. Abdominal, upper and lower limb exercises, shoulder and full arm circling, weight-lifting, and other exercises. Each exercise repeated 8--10 times over 45 min Three 1 h sessions a week for 12 weeks with 15 min of respiratory physiotherapy every session and 45 min of education during weeks 1, 6+12                                            Low intensity peripheral muscle training. One session a week for 9 months                                                                                                                                                                                                                                                                                                                                            \(1\) CRQ\
                                                                                                   Con: n=23\                          Con: 60% (56--64)\                                                                                              Exclusion: musculoskeletal conditions affecting ability to exercise; terminal illness/other severe disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             (2) Pulmonary function, 6MWT, hospital admissions, GP visits, exacerbations
                                                                                                   RHB: n=22\                          RHB: 60% (55--65)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                   RHBM: n=26\                         RHBM: 61% (56--66) Current smokers\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                   Males: n=58\                        Con: n=8\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                   Females: n=13 Age, mean (95% CI)\   RHB: n=7\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                   RHBM: 65 (62--68)\                  RHBM: n=9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                   RHB: 64 (60--68)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                   Con: 63 (60--66)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Moullec et al (2008)[@b23-copd-13-257] and Moullec and Ninot (2010)[@b24-copd-13-257] (France)   40 participants\                    FEV~1~%pred, mean ± SD\                                                                                         Inclusion: FEV~1~/FVC \<0.7, FEV~1~ 30%--79% predicted; no indication for home oxygen therapy; stable state for the previous 2 months; no change in medication and symptoms for the previous 4 weeks; \>40 years of age; no previous pulmonary rehabilitation experience Exclusion: medical or psychiatric disturbances that would hinder program participation; diagnosis of asthma; congestive left heart failure; terminal disease                                  Determine changes in the emotional and functional dimensions of QoL in COPD 1 year after a pulmonary rehabilitation program with or without a follow-up intervention Quasi-RCT, individual                                     Twenty inpatient sessions over 4 weeks                                                                                                                                                                                                                                                                                                                                                                      Community gymnasium Individualized strength, interval, breathing, and endurance training with nature walking at ventilatory threshold 96 sessions across 12 months. Exercise training (3.5 h/week; 72 sessions); health education (2 h/month; 12 sessions); psychosocial support (with discussion group 1 h/month; 12 sessions)                                                                                      \(1\) 6MWT, QoL (SGRQ and WHOQoL-Brief)\
                                                                                                   Int: n=14\                          Int: 53±16%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (2) Six-item questionnaire with a VAS, maximal exercise capacity, physical activity, health care utilization, attendance, pulmonary function
                                                                                                   Con: n=26 Males: n=31\              Con: 47±19% No data available on smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                   Females: n=9 Age, mean ± SD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                   Int: 63±7\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Con: 60±10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Guell et al (2017)25 (Spain)                                                                     138 participants\                   FEV~1~%pred, mean ± SD\                                                                                         Inclusion: COPD diagnosis (grade II--IV severity); clinically stable during previous 4 weeks; 18--75 years old; exsmokers or with intention to quit; BODE index value between 3 and 10\                                                                                                                                                                                                                                                                                Assess the efficacy of a supervised maintenance program after pulmonary rehabilitation on improving symptoms, exercise capacity, and health-related QoL compared to just pulmonary rehabilitation on its own RCT, individual   Three hospital-based 2 h sessions a week for 8 weeks. Supplemented with four education sessions and chest physiotherapy 30 min weight-lifting (0.5 kg in each hand, increased by 1 kg a week until peak tolerance), 30 min leg cycling (start at 50% maximum load achieved during initial exercise test, load increased by 10 W if heart rate and oxygen saturation are stable and exercise is tolerated)   Supervised exercise on alternate weeks at hospital for 36 months. Unsupervised home exercise program (3 days a week) similar to hospital program (15 min chest physiotherapy, 30 min arm training, 30 min leg training). Supplemented by structured phone calls from physiotherapists every 15 days Exercise similar to pulmonary rehabilitation. Exercises, if well tolerated, were progressed at hospital visits   1\) BODE index\
                                                                                                   Int: n=68\                          Int: 34±11%\                                                                                                    Exclusion: bronchodilator response (FEV~1~ increment \>15% of the baseline value after 200 μg of inhaled bronchodilator); other respiratory diagnoses; severe coronary artery disease; orthopedic diseases limiting mobility; life expectancy \<2 years; inability to cooperate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        (2) 6MWT, health-related QoL, and CRQ
                                                                                                   Con: n=70\                          Con: 34±9%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                   Males: n=123\                       No data available on smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                   Females: n=15 Age, mean ± SD\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                   Int: 64±9\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                   Con: 64±8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** BMI, body mass index; BODE, body mass index, airflow obstruction, dyspnea, and exercise index; Con, control group; Int, intervention group; CRQ, chronic respiratory questionnaire; ESWT, endurance shuttle walk test; EQ5D, Euro Quality of Life Five Dimensions questionnaire; FEV~1~%pred, forced expiratory volume in 1 s % of predicted; FVC, forced vital capacity; GP, general practitioner; HADS, hospital anxiety and depression scale; ISWT, incremental shuttle walk test; 6MWT, 6 min walk test; QoL, quality of life; RCT, randomized controlled trial; RHB, pulmonary rehabilitation with no maintenance; RHBM, pulmonary rehabilitation with maintenance; SD, standard deviation; SGRQ, St George's Respiratory Questionnaire; VAS, visual analog scale; WHOQoL-Brief, World Health Organization Quality of Life Brief questionnaire.

###### 

Risk of bias assessment

  Study                                                                                   Random sequence generation   Allocation concealment   Blind outcome assessment   Incomplete outcome data   Selective reporting (reporting bias)   Other bias   Overall risk
  --------------------------------------------------------------------------------------- ---------------------------- ------------------------ -------------------------- ------------------------- -------------------------------------- ------------ --------------
  Ries et al (2003)[@b16-copd-13-257]                                                     Low                          Low                      Low                        Low                       Low                                    Low          Low
  Brooks et al (2002)[@b17-copd-13-257]                                                   Low                          Low                      Unclear                    High                      Low                                    Low          Medium
  Spencer et al (2010)[@b18-copd-13-257]                                                  Low                          Low                      High                       Low                       Low                                    Low          Medium
  Ringbaek et al (2010)[@b19-copd-13-257]                                                 Unclear                      Unclear                  Unclear                    Low                       Low                                    Low          High
  Wilson et al (2015)[@b20-copd-13-257] and Burns et al (2016)[@b21-copd-13-257]          Low                          Low                      Low                        High                      Low                                    Low          Medium
  Roman et al (2013)[@b22-copd-13-257]                                                    Low                          Unclear                  Unclear                    High                      Low                                    Low          High
  Moullec et al (2008)[@b23-copd-13-257] and Moullec and Ninot (2010)[@b24-copd-13-257]   High                         High                     Unclear                    High                      Low                                    Low          High
  Guell et al (2017)[@b25-copd-13-257]                                                    Low                          Low                      Unclear                    High                      High                                   Low          High
